About this trial
This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.
Eligibility criteria
Qualifiers
Meet the new 2023 ARDS global definition;
Age 18-80 years
Disqualifiers
Expected death within 24 hours of screening;
Metastatic cancer (active malignancy with distant metastases);
Severe psychiatric disorders;
Pregnancy or postpartum status;
Trial design
Treatments tested in this trial
- Not applicable- observational study
Treatment groups
Sponsors and collaborators
XiaoJing Zou,MD
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Sponsor institution